Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expressionA Hemminki, N Belousova, K R Zinn, et al.
Human Molecular Genetics|January 15, 1999
Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancerA Ylikorkala, E Avizienyte, I P Tomlinson, et al.
Gene Therapy|March 16, 2002
Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFvW O Arafat, J Gómez-Navarro, D J Buchsbaum, et al.
International Journal of Cancer|November 20, 2013
In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus respondersO Hemminki, R Immonen, J Närväinen, et al.
Cancer Gene Therapy|September 4, 2023
Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokineD C A Quixabeira, E Jirovec, S Pakola, et al.
Cancer Gene Therapy|November 10, 2023
Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancerD C A Quixabeira, S Pakola, E Jirovec, et al.
Gene Therapy|March 19, 2010
Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumorsS Pesonen, P Nokisalmi, S Escutenaire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applicationsE Casado, J Gomez-Navarro, M Yamamoto, et al.
Nature|January 15, 1998
A serine/threonine kinase gene defective in Peutz-Jeghers syndromeA Hemminki, D Markie, I Tomlinson, et al.
Oncoimmunology|July 4, 2015
Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8+ T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancerL Vassilev, T Ranki, T Joensuu, et al.
Pageof 7